
    
      Single centre, randomised, double-blind, placebo-controlled study of single ascending doses
      in 10 sequential groups of 8 healthy young male volunteers. Within each group (n=8), 6
      volunteers were randomised to receive BIA 5-453 and the remaining 2 volunteers were
      randomised to receive placebo. A volunteer participated only in a single period.
    
  